Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00515697
Status:
COMPLETED
Last Update Posted:
2014-06-18
First Post:
2007-08-13
Brief Title:
A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Renal Cell Carcinoma |
Keywords: